Please provide your email address to receive an email when new articles are posted on . Radiofrequency ablation had a technical efficacy of 96.1% for adults with low-risk thyroid cancer. Tumor ...
CAESAREA, Israel, Oct. 7, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that ...
The aim is a user-friendly complete system for more targeted and thus more effective thermal ablation. Fraunhofer MEVIS is exclusively licensing its SAFIR technology (Software Assistant for ...
Six-year outcomes from the FROST trial show breast cancer cryoablation achieved low ipsilateral recurrence and high invasive ...
From the Medical and Surgical Services and the Department of Pathology, Beth Israel Hospital, Boston, and the Department of Medicine, Harvard Medical School, Boston. Dameshek, William — Associate ...
Article published in European Journal of Surgical Oncology focused on cosmetic outcomes and patient satisfaction reports 95% of patients were very satisfied or satisfied with thermal ablation Article ...
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE, “the Company”), a company primarily focused on leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results